165 | Annual Report | 2025-2026 (ii) Details of grant and exercise of such options are as follows: Particulars ESOP 2010 (grant 2017) ESOP 2018 (grant 2018) ESOP 2018 (grant 2019) ESOP 2018 (grant 2020) ESOP 2021 (grant 2021) ESOP 2021 (grant 2022) ESOP 2021 (grant 2023) ESOP 2021 (grant 2024) ESOP 2021 (grant 2025) Number of option granted 2,29,280 5,97,264 7,69,528 8,42,858 9,82,867 9,97,942 13,91,143 18,07,444 12,55,672 March 31, 2026 Outstanding number of options 98,000 3,74,824 4,76,305 5,25,549 6,49,951 7,26,525 11,43,533 14,71,397 12,21,422 Exercisable number of options 98,000 3,74,824 4,76,305 5,25,549 6,49,951 7,26,525 7,62,355 4,90,466 - March 31, 2025 Outstanding number of options 98,000 3,74,824 4,76,305 5,31,549 6,56,551 7,36,508 11,81,683 15,74,964 - Exercisable number of options 98,000 3,74,824 4,76,305 5,31,549 6,56,551 4,91,005 3,93,894 - - (iii) The weighted average exercise price and remaining contractual life of the ESOP Scheme are as follows: Particulars ESOP 2010 (grant 2017) ESOP 2018 (grant 2018) ESOP 2018 (grant 2019) ESOP 2018 (grant 2020) ESOP 2021 (grant 2021) ESOP 2021 (grant 2022) ESOP 2021 (grant 2023) ESOP 2021 (grant 2024) ESOP 2021 (grant 2025) March 31, 2026 Exercise price 84.70 130.00 162.80 170.00 210.00 153.94 124.00 148.35 148.35 Weighted average remaining contractual life (in years) - - - - - - 0.41 1.42 2.41 March 31, 2025 Exercise price 84.70 130.00 162.80 170.00 210.00 153.94 124.00 148.35 - Weighted average remaining contractual life (in years) - - - - - 0.38 1.41 2.42 - (iv) Reconciliation of stock options: Particulars ESOP 2010 (grant 2017) ESOP 2018 (grant 2018) ESOP 2018 (grant 2019) ESOP 2018 (grant 2020) ESOP 2021 (grant 2021) ESOP 2021 (grant 2022) ESOP 2021 (grant 2023) ESOP 2021 (grant 2024) ESOP 2021 (grant 2025) Outstanding as at March 31, 2024 98,000 3,88,824 5,08,705 5,60,349 7,24,391 8,17,675 13,52,293 - - Stock option issued during the year - - - - - - - 18,07,444 - Add: Stock option exercised and vested - - - - - - - - - Less: Stock option forfeited/ lapsed - 14,000 32,400 28,800 67,840 81,167 1,70,610 2,32,480 - Outstanding as at March 31, 2025 98,000 3,74,824 4,76,305 5,31,549 6,56,551 7,36,508 11,81,683 15,74,964 - Stock option issued during the year - - - - - - - - 12,55,672 Add: Stock option exercised and vested - - - - - - - - - Less: Stock option forfeited/ lapsed - - - 6,000 6,600 9,983 38,150 1,03,567 34,250 Outstanding as at March 31, 2026 98,000 3,74,824 4,76,305 5,25,549 6,49,951 7,26,525 11,43,533 14,71,397 12,21,422 (v) The Company has recognized share based payment expense of ₹1,034.98 lakhs (March 31, 2025: ₹760.25 lakhs) during the year as proportionate cost. (Refer note 37). Arohan Financial Services Limited Notes to financial statements for the year ended March 31, 2026 (cont’d) (All amounts in ₹ lakhs unless otherwise stated) Note 27: Employee stock option scheme (‘ESOP Scheme’) (cont’d)
RkJQdWJsaXNoZXIy NTE5NzY=